Skip to main content

Recce Pharmaceuticals Ltd RCE View profile

Recce Pharmaceuticals advances R327 as diabetes and antibiotic resistance burdens converge

Published 02/09

Share X in f @

Friday 23 October

Today’s Edition

Snowy 2.0 cost blows out to as much as A$25 billion as completion slips to 2029

By Ephrem Joseph 05:00

Fortescue warns China iron ore dispute could force production cuts

By Ephrem Joseph 03:44

Australia scrambles to patch critical internet flaw affecting millions of websites

By Ephrem Joseph 02:43

AI and offshoring reshape Australian banking as thousands of jobs disappear

By Ephrem Joseph 01:41